[go: up one dir, main page]

NO871879D0 - Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser. - Google Patents

Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.

Info

Publication number
NO871879D0
NO871879D0 NO871879A NO871879A NO871879D0 NO 871879 D0 NO871879 D0 NO 871879D0 NO 871879 A NO871879 A NO 871879A NO 871879 A NO871879 A NO 871879A NO 871879 D0 NO871879 D0 NO 871879D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutically active
heterocyclic compounds
new therapeutically
Prior art date
Application number
NO871879A
Other languages
English (en)
Other versions
NO871879L (no
Inventor
Richard Anthony Appleton
Sidney Clifford Burford
John Dixon
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868611102A external-priority patent/GB8611102D0/en
Priority claimed from GB868630906A external-priority patent/GB8630906D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of NO871879D0 publication Critical patent/NO871879D0/no
Publication of NO871879L publication Critical patent/NO871879L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO871879A 1986-05-07 1987-05-06 Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser. NO871879L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868611102A GB8611102D0 (en) 1986-05-07 1986-05-07 Heterocyclic compounds
GB868630906A GB8630906D0 (en) 1986-12-24 1986-12-24 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
NO871879D0 true NO871879D0 (no) 1987-05-06
NO871879L NO871879L (no) 1987-11-09

Family

ID=26290729

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871879A NO871879L (no) 1986-05-07 1987-05-06 Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.

Country Status (13)

Country Link
US (1) US4803216A (no)
EP (1) EP0248523B1 (no)
KR (1) KR870011101A (no)
AT (1) AT390732B (no)
AU (1) AU595602B2 (no)
CA (1) CA1305157C (no)
DE (1) DE3773746D1 (no)
DK (1) DK231687A (no)
FI (1) FI871974L (no)
IL (1) IL82421A0 (no)
NO (1) NO871879L (no)
NZ (1) NZ220214A (no)
PT (1) PT84831B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
DE4234886A1 (de) * 1992-10-16 1994-04-21 Wella Ag Neue N-Phenylaminopyrazol-Derivate sowie Mittel und Verfahren zur Färbung von Haaren
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5500439A (en) * 1993-12-09 1996-03-19 Alteon Inc. Aminopyrazoles
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
WO1996000218A1 (en) * 1994-06-24 1996-01-04 Euro-Celtique, S.A. Compounds for and method of inhibiting phosphodiesterase iv
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
EP0814809B1 (en) * 1994-12-13 2003-08-13 Euroceltique S.A. Aryl thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2004076414A2 (en) * 2003-02-27 2004-09-10 Smithkline Beecham Corporation Novel compounds
GB0326601D0 (en) * 2003-11-14 2003-12-17 Novartis Ag Organic compounds
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
CN101827836B (zh) 2007-10-18 2014-02-19 詹森药业有限公司 三取代的1,2,4-三唑化合物
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
EP2257535B1 (en) 2008-03-19 2013-11-06 Janssen Pharmaceutica N.V. Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators
TWI440634B (zh) * 2008-05-09 2014-06-11 Janssen Pharmaceutica Nv 經三取代之吡唑類
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN102574832B (zh) 2009-09-17 2014-09-24 詹森药业有限公司 取代的n-苯基-1-(4-吡啶基)-1h-吡唑-3-胺
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US9828351B2 (en) * 2014-06-26 2017-11-28 Monash University Enzyme interacting agents
WO2019156439A1 (en) 2018-02-07 2019-08-15 Korea Research Institute Of Chemical Technology Compounds for inhibiting tnik and medical uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD211343A1 (de) * 1982-11-08 1984-07-11 Univ Ernst Moritz Arndt Verfahren zur synthese von pyrazolen
EP0178035B1 (en) * 1984-05-12 1990-01-03 FISONS plc Anti-inflammatory 1,n-diarylpyrazol-3-amines, compositions containing them and processes for their preparation

Also Published As

Publication number Publication date
NO871879L (no) 1987-11-09
ATA290487A (de) 1989-12-15
FI871974A7 (fi) 1987-11-08
AU595602B2 (en) 1990-04-05
EP0248523A1 (en) 1987-12-09
US4803216A (en) 1989-02-07
FI871974L (fi) 1987-11-08
IL82421A0 (en) 1987-11-30
AT390732B (de) 1990-06-25
EP0248523B1 (en) 1991-10-16
DE3773746D1 (en) 1991-11-21
NZ220214A (en) 1990-06-26
PT84831A (en) 1987-06-01
FI871974A0 (fi) 1987-05-05
DK231687D0 (da) 1987-05-06
KR870011101A (ko) 1987-12-21
PT84831B (pt) 1990-02-08
CA1305157C (en) 1992-07-14
DK231687A (da) 1987-11-08
AU7258487A (en) 1987-11-12

Similar Documents

Publication Publication Date Title
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO895086D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO891191D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk virksomme catecholderivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO900032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO169485C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive, substituerte benzamidderivater
NO163184C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO823520L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive carbohydrater.
NO870998D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO157864C (no) Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater.
NO893784L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktiveimidazolderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO865148L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.